Další formáty:
BibTeX
LaTeX
RIS
@article{2243094, author = {Klincová, Martina and Štěpánková, Dagmar and Schröderová, Ivana and Klabusayová, Eva and Štourač, Petr}, article_location = {BASEL, SWITZERLAND}, article_number = {11}, doi = {http://dx.doi.org/10.3390/children9111692}, keywords = {malignant hyperthermia; children; PICU; critical; triggers; sevoflurane; succinylcholine; dantrolene; cooling; RYR1}, language = {eng}, issn = {2227-9067}, journal = {Children-Basel}, title = {Malignant Hyperthermia in PICU-From Diagnosis to Treatment in the Light of Up-to-Date Knowledge}, url = {https://www.mdpi.com/2227-9067/9/11/1692}, volume = {9}, year = {2022} }
TY - JOUR ID - 2243094 AU - Klincová, Martina - Štěpánková, Dagmar - Schröderová, Ivana - Klabusayová, Eva - Štourač, Petr PY - 2022 TI - Malignant Hyperthermia in PICU-From Diagnosis to Treatment in the Light of Up-to-Date Knowledge JF - Children-Basel VL - 9 IS - 11 SP - 1-7 EP - 1-7 PB - MDPI AG SN - 22279067 KW - malignant hyperthermia KW - children KW - PICU KW - critical KW - triggers KW - sevoflurane KW - succinylcholine KW - dantrolene KW - cooling KW - RYR1 UR - https://www.mdpi.com/2227-9067/9/11/1692 N2 - Malignant Hyperthermia (MH) is a rare, hereditary, life-threatening disease triggered by volatile anesthetics and succinylcholine. Rarely, MH can occur after non-pharmacological triggers too. MH was detected more often in children and young adults, which makes this topic very important for every pediatric specialist, both anesthesiologists and intensivists. MH crisis is a life-threatening severe hypermetabolic whole-body reaction. Triggers of MH are used in pediatric intensive care unit (PICU) as well, volatile anesthetics in difficult sedation, status asthmaticus or epilepticus, and succinylcholine still sometimes in airway management. Recrudescence or delayed onset of MH crisis hours after anesthesia was previously described. MH can also be a cause of rhabdomyolysis and hyperpyrexia in the PICU. In addition, patients with neuromuscular diseases are often admitted to PICU and they might be at risk for MH. The most typical symptoms of MH are hypercapnia, tachycardia, hyperthermia, and muscle rigidity. Thinking of the MH as the possible cause of deterioration of a patient's clinical condition is the key to early diagnosis and treatment. The sooner the correct treatment is commenced, the better patient's outcome. This narrative review article aims to summarize current knowledge and guidelines about recognition, treatment, and further management of MH in PICU. ER -
KLINCOVÁ, Martina, Dagmar ŠTĚPÁNKOVÁ, Ivana SCHRÖDEROVÁ, Eva KLABUSAYOVÁ a Petr ŠTOURAČ. Malignant Hyperthermia in PICU-From Diagnosis to Treatment in the Light of Up-to-Date Knowledge. \textit{Children-Basel}. BASEL, SWITZERLAND: MDPI AG, 2022, roč.~9, č.~11, s.~1-7. ISSN~2227-9067. Dostupné z: https://dx.doi.org/10.3390/children9111692.
|